Sort   by:  
 Page size 
UnknownShaping learning objectives for biomedical artificial intelligence: Student-centered insights into novel cell visualization technology.
Not available
S-EPMC12505238 | biostudies-literature
UnknownSummer Research Internship Curriculum to Promote Self-Efficacy, Researcher Identity, and Peer-to-Peer Learning: Retrospective Cohort Study.
Not available
S-EPMC11809269 | biostudies-literature
UnknownThe sponge microbiome project.
Not available
S-EPMC5632291 | biostudies-literature
UnknownHigh Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.
Not available
S-EPMC5049609 | biostudies-literature
UnknownGenotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.
Not available
S-EPMC5777934 | biostudies-literature
UnknownManaging food allergy: GA2LEN guideline 2022.
Not available
S-EPMC9467869 | biostudies-literature
UnknownMosquito genomics. Highly evolvable malaria vectors: the genomes of 16 Anopheles mosquitoes.
Not available
S-EPMC4380271 | biostudies-literature
UnknownSafety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Not available
S-EPMC8639161 | biostudies-literature
UnknownSafety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Not available
S-EPMC9084623 | biostudies-literature
UnknownRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Not available
S-EPMC8185188 | biostudies-literature
Sort   by:  
 Page size